Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Havemann-Reinecke

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
European Archives of Psychiatry and Clinical Neuroscience|October 7, 2022
Concentrations of escitalopram in blood of patients treated in a naturalistic setting: focus on patients with alcohol and benzodiazepine use disorderX M Hart, S Heesen, C N Schmitz, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|January 30, 2003
Lack of association between hippocampal volume reduction and first-onset alcohol withdrawal seizure. A volumetric MRI studyS Bleich, W Sperling, D Degner, et al.
Addiction Biology|September 1, 2016
Chronic exposure to cannabinoids during adolescence causes long-lasting behavioral deficits in adult miceJ Tomas-Roig, E Benito, R C Agis-Balboa, et al.
Neuroscience Letters|January 18, 2003
Hyperhomocysteinemia as a new risk factor for brain shrinkage in patients with alcoholismS Bleich, B Bandelow, K Javaheripour, et al.
Alcoholism, Clinical and Experimental Research|August 10, 2005
Advances in alcoholism research in GermanyL G Schmidt, S Bleich, J Boening, et al.
Psychopharmacology|October 19, 2023
Venlafaxine's therapeutic reference range in the treatment of depression revised: a systematic review and meta-analysisX M Lense, C Hiemke, C S M Funk, et al.
Behavioural Brain Research|January 28, 2016
Social defeat leads to changes in the endocannabinoid system: An overexpression of calreticulin and motor impairment in miceJ Tomas-Roig, F Piscitelli, V Gil, et al.
Pharmacopsychiatry|October 5, 2011
AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011C Hiemke, P Baumann, N Bergemann, et al.
Pharmacopsychiatry|November 5, 2011
AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011C Hiemke, P Baumann, N Bergemann, et al.
Pharmacopsychiatry|February 2, 2018
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017C Hiemke, N Bergemann, H W Clement, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
European Archives of Psychiatry and Clinical Neuroscience|October 7, 2022
Concentrations of escitalopram in blood of patients treated in a naturalistic setting: focus on patients with alcohol and benzodiazepine use disorderX M Hart, S Heesen, C N Schmitz, et al.
Alcohol and Alcoholism (Oxford, Oxfordshire)|January 30, 2003
Lack of association between hippocampal volume reduction and first-onset alcohol withdrawal seizure. A volumetric MRI studyS Bleich, W Sperling, D Degner, et al.
Addiction Biology|September 1, 2016
Chronic exposure to cannabinoids during adolescence causes long-lasting behavioral deficits in adult miceJ Tomas-Roig, E Benito, R C Agis-Balboa, et al.
Neuroscience Letters|January 18, 2003
Hyperhomocysteinemia as a new risk factor for brain shrinkage in patients with alcoholismS Bleich, B Bandelow, K Javaheripour, et al.
Alcoholism, Clinical and Experimental Research|August 10, 2005
Advances in alcoholism research in GermanyL G Schmidt, S Bleich, J Boening, et al.
Psychopharmacology|October 19, 2023
Venlafaxine's therapeutic reference range in the treatment of depression revised: a systematic review and meta-analysisX M Lense, C Hiemke, C S M Funk, et al.
Behavioural Brain Research|January 28, 2016
Social defeat leads to changes in the endocannabinoid system: An overexpression of calreticulin and motor impairment in miceJ Tomas-Roig, F Piscitelli, V Gil, et al.
Pharmacopsychiatry|October 5, 2011
AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011C Hiemke, P Baumann, N Bergemann, et al.
Pharmacopsychiatry|November 5, 2011
AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: update 2011C Hiemke, P Baumann, N Bergemann, et al.
Pharmacopsychiatry|February 2, 2018
Consensus Guidelines for Therapeutic Drug Monitoring in Neuropsychopharmacology: Update 2017C Hiemke, N Bergemann, H W Clement, et al.
Pageof 3